JOURNAL OF THE CZECH PHARMACEUTICAL SOCIETY AND THE SLOVAK PHARMACEUTICAL SOCIETY

Čes. slov. farm. 2006, 55(2):78-83

Morin in the Therapy of the Ischemia-Reperfusion Damage Model of the Rat Kidney

L. Bartošíková1, J. Nečas1, V. Suchý2, D. Jankovská2, E. Janoštíková1, T. Bartošík3, J. Klusáková4, J. Juřica5, T. Florian1, M. Frydrych1, J. Krčmář1, P. Fráňa6, J. Fráňová7
1 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav humánní farmakologie a toxikologie
2 Veterinární a farmaceutická univerzita Brno, Farmaceutická fakulta, Ústav přírodních léčiv
3 Úrazová nemocnice, Brno
4 Lékařská fakulta Masarykovy univerzity, I. Patologicko-anatomický ústav, Brno
5 Lékařská fakulta Masarykovy univerzity, Farmakologický ústav, Brno
6 Fakultní nemocnice U sv. Anny, II. interní klinika, Brno
7 Dětská nemocnice FN, Brno

The aim of this study was to analyze the protective effects of morin administered during the therapy of reperfusion injury of the laboratory rat kidney. Animals were randomly divided into five groups (n=10). One group was left intact. Three medicated groups and one placebo group were subjected to ischemia (60 min) and reperfusion of the left kidney. Morin was suspended in a 2 ml of 0.5% Avicel solution and administered orally by a gastric probe at doses of 5, 10, and 20 mg.kg-1 once a day for 15 days. The placebo group was given only 2 ml of 0.5% Avicel in the same way. On the 15th day, all the animals were exsanguinated and the reperfused kidneys were recovered. Selected biochemical markers in blood were assessed: superoxide dismutase, glutathion peroxidase, total antioxidative capacity, malondialdehyde, creatinine, urea, and uric acid. Creatinine, urea, and total protein were analyzed in urine, and a 24-hour diuresis was recorded. The kidney tissue samples were used for histopathological examination. Morin supported the organism's own defensive reactions against free radicals and decreased lipid peroxidation in the cell membranes and contributed to the recovery of kidney functions. The histopathological results confirm 20 mg.kg-1 as the most effective dose.

Keywords: antioxidative effect; ischemia-reperfusion; kidney; morin; therapy

Received: November 25, 2005; Accepted: January 2, 2006; Published: February 1, 2006  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bartošíková L, Nečas J, Suchý V, Jankovská D, Janoštíková E, Bartošík T, et al.. Morin in the Therapy of the Ischemia-Reperfusion Damage Model of the Rat Kidney. Čes. slov. farm. 2006;55(2):78-83.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Calomme, M., Pieters, L., Vlietinck, A., Vanden Berghe, D.: Planta Med., 1996; 62, 222-226. Go to original source... Go to PubMed...
    2. Read, M. A.: Am. J. Pathol., 1995; 147, 235-237. Go to original source...
    3. Perez, R. M., Zaval, M. A., Perez, S., Perez, C.: Phytomed., 1998; 5, 55-57.
    4. Yamamura, S., Ozawa, K., Ohtani, K. et al.: Phytochem., 1998; 48, 131-136. Go to original source...
    5. Jovanovic, S. V., Steenken, S., Tosic, M. et al.: J. Am. Chem. Soc., 1994; 116, 4846-4851. Go to original source...
    6. RiceEvans, C. A., Miller, N. J., Bolwell, P. G. et al.: Free Rad. Res., 1995; 22, 375-383. Go to original source... Go to PubMed...
    7. Kubínová, R., Suchý, V.: Čes. slov. Farm., 1999; 48, 9-14. Go to original source...
    8. Catapano, A. L.: Angiology, 1997; 48, 39-44. Go to original source... Go to PubMed...
    9. Urquiaga, I., Leighton, F.: Biol. Res., 2000; 33, 55-64. Go to original source... Go to PubMed...
    10. Zhong, Z., Connor, H. D., Froh, M. et al.: Free Radic. Biol. Med., 2004; 36, 1248-1258. Go to original source... Go to PubMed...
    11. Aherne, S. A., O'Brien, N. M.: Nutrition, 2002; 18, 7581. Go to original source... Go to PubMed...
    12. Bartošíková, L., Nečas, J., Suchý, V. et al.: Acta Vet., 2003a; 72, 191-200.
    13. Bartošíková, L., Nečas, J., Suchý, V. et al.: Acta Vet., 2003b; 72, 87-94.
    14. Uchiyama, M., Mihara, M.: Anal. Biochem., 1978; 3, 271-278. Go to original source... Go to PubMed...
    15. Ogata, M., Iwamoto, T., Tazawa, N. et al.: Eur. J. Pharmacol., 2003; 478, 187-198. Go to original source... Go to PubMed...
    16. Lieberthal, W., Levine, J. S.: Am. J. Physiol., 1996; 271, F 477-488. Go to original source... Go to PubMed...
    17. Edelstein, C. L., Ling, H., Schrier, R. W.: Kidney Int, 1997; 51, 1341-1351. Go to original source... Go to PubMed...
    18. Tani, M., Neely, J. R.: Circ. Res., 1989; 65, 1045-1056. Go to original source... Go to PubMed...
    19. Kuro, T., Kobayashi, Y., Takaoka, M., Matsumura, Y.: Jpn. J. Pharmacol., 1999; 81, 247-251. Go to original source... Go to PubMed...
    20. Carattino, M. D., Cueva, F., Zuccollo, A. et al.: Immunopharmacol., 1999; 43, 241-248.
    21. MimicOka, J., Simic, T., Ekmescic, V., Dragicevic, P.: Clin. Nephrol., 1995; 44, 44-48.
    22. Racek, J., Veselá, E., Holeček, V., Treska, V.: The significance of free radicals in patients with renal failure and during kidney transplantation. Klin. Biochem. Metab., 1995; 24suppl, 4-6.
    23. Durak, I., Akyol, O., Baseme, E. et al.: Nephron, 1994; 66, 76-80. Go to original source... Go to PubMed...
    24. Bonomini, M., Albertazzi, A.: Artif Organs, 1995; 19, 443-448. Go to original source... Go to PubMed...
    25. Racek, J., Eiselt, J., Holeček, V. et al.: Klin. Biochem. Metab., 1997; 26, 92-97.
    26. Toborek, M., Wasik, L., Drozdz, M. et al.: Metabolism Clin. Exp., 1992; 41, 1299-1232 Go to original source... Go to PubMed...
    27. Jackson, P., Loughrey, C. M., Lightbody, J. H. et al.: Clin. Chem., 1995; 41, 1135-1138. Go to original source...
    28. Roselaar, S. E., Naznat, N. B., Winyard, P. G. et al.: Kidney Int., 1995; 48, 199-206. Go to original source... Go to PubMed...
    29. Singh, D., Chopra, K.: Pharmacol. Res., 2004; 50, 187-193. Go to original source... Go to PubMed...
    30. Lee, P. H., Chung, Y. C., Hu, R. H. et al.: Transpl. Proc., 1992; 24, 1353-1354.
    31. Zurovsky, Y., Eligal, Z., Grossman, S.: Exp. Toxic. Path., 1995; 47, 471-478. Go to original source... Go to PubMed...
    32. Kollár, P., Kotolová, H.: Biologické účinky resveratrolu a dalších obsahových látek vína. Čes. slov. Farm., 2003; 52, 272-281.

    Return to the content


    Czech and Slovak Pharmacy

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.